Search research articles
Contact Us
Filters
Showing results (91-100 of 107) with videos related to
Page
of 11
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 13, 2011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee
Michael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Haematologica
|
October 20, 2022
Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia
Alan S Wayne, Van Huynh, Nobuko Hijiya, et al.
Cancer Immunology Research
|
May 17, 2022
Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects
Francesco Ceppi, Ashley L Wilson, Colleen Annesley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 10, 2006
Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis
Kouhei Yamashita, Mitchell E Horwitz, Akua Kwatemaa, et al.
Lancet (London, England)
|
October 17, 2014
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, et al.
Haematologica
|
February 3, 2022
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)
Sarah K Tasian, Lewis B Silverman, James A Whitlock, et al.
Journal of the National Cancer Institute
|
July 4, 2024
Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium
Eric S Schafer, Teresa Rushing, Kristine R Crews, et al.
Pediatric Blood & Cancer
|
January 17, 2020
Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemia
Nirali N Shah, Deepa Bhojwani, Keith August, et al.
Blood Neoplasia
|
June 30, 2026
Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic leukemia: a TACL consortium report
Eric S Schafer, Holly L Pacenta, Yueh-Yun Chi, et al.
Blood
|
April 2, 2011
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States
Jeffrey I Cohen, Elaine S Jaffe, Janet K Dale, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 107) with videos related to
Sort By:
Page
of 11
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 13, 2011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee
Michael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Haematologica
|
October 20, 2022
Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia
Alan S Wayne, Van Huynh, Nobuko Hijiya, et al.
Cancer Immunology Research
|
May 17, 2022
Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects
Francesco Ceppi, Ashley L Wilson, Colleen Annesley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 10, 2006
Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis
Kouhei Yamashita, Mitchell E Horwitz, Akua Kwatemaa, et al.
Lancet (London, England)
|
October 17, 2014
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, et al.
Haematologica
|
February 3, 2022
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)
Sarah K Tasian, Lewis B Silverman, James A Whitlock, et al.
Journal of the National Cancer Institute
|
July 4, 2024
Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium
Eric S Schafer, Teresa Rushing, Kristine R Crews, et al.
Pediatric Blood & Cancer
|
January 17, 2020
Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemia
Nirali N Shah, Deepa Bhojwani, Keith August, et al.
Blood Neoplasia
|
June 30, 2026
Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic leukemia: a TACL consortium report
Eric S Schafer, Holly L Pacenta, Yueh-Yun Chi, et al.
Blood
|
April 2, 2011
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States
Jeffrey I Cohen, Elaine S Jaffe, Janet K Dale, et al.
Page
of 11